Elderly and younger patients with non-small cell lung cancer (NSCLC) derive similar benefit from second-line chemotherapy: A retrospective subset analysis of second-line chemotherapy trials conducted from the Hellenic Cooperative Research Group (HORG).
Sofia Agelaki
No relevant relationships to disclose
Dora Hatzidaki
No relevant relationships to disclose
Lampros Vamvakas
No relevant relationships to disclose
Athanasios G. Pallis
No relevant relationships to disclose
Athanasios Karampeazis
No relevant relationships to disclose
Athina Agelidou
No relevant relationships to disclose
Maria Agelidou
No relevant relationships to disclose
Vassilis Chandrinos
No relevant relationships to disclose
Aristidis Polyzos
No relevant relationships to disclose
Vassilis Georgoulias
Consultant or Advisory Role - Amgen (U); GlaxoSmithKline (U); Janssen-Cilag (U); Novartis (U); Sanofi (U)
Honoraria - Amgen; GlaxoSmithKline; Janssen-Cilag; Novartis; Sanofi
Research Funding - Amgen; GlaxoSmithKline; Janssen-Cilag; Novartis; Sanofi